These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 7585040)
1. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Malhotra R; Wormald MR; Rudd PM; Fischer PB; Dwek RA; Sim RB Nat Med; 1995 Mar; 1(3):237-43. PubMed ID: 7585040 [TBL] [Abstract][Full Text] [Related]
2. Glycobiology: 'the function of sugar in the IgG molecule'. Dwek RA; Lellouch AC; Wormald MR J Anat; 1995 Oct; 187 ( Pt 2)(Pt 2):279-92. PubMed ID: 7591992 [TBL] [Abstract][Full Text] [Related]
3. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis. Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507 [TBL] [Abstract][Full Text] [Related]
4. Agalactosyl IgG and mannose-binding proteins: biochemical nicety or pathophysiological paradigm? Ezekowitz RA Nat Med; 1995 Mar; 1(3):207-8. PubMed ID: 7585032 [No Abstract] [Full Text] [Related]
5. Lectin-carbohydrate interactions in disease. T-cell recognition of IgA and IgD; mannose binding protein recognition of IgG0. Rudd P; Fortune F; Lehner T; Parekh R; Patel T; Wormald M; Malhotra R; Sim R; Dwek R Adv Exp Med Biol; 1995; 376():147-52. PubMed ID: 8597241 [TBL] [Abstract][Full Text] [Related]
6. Isotype and glycoform selection for antibody therapeutics. Jefferis R Arch Biochem Biophys; 2012 Oct; 526(2):159-66. PubMed ID: 22465822 [TBL] [Abstract][Full Text] [Related]
7. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885 [TBL] [Abstract][Full Text] [Related]
8. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303 [TBL] [Abstract][Full Text] [Related]
9. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Bond A; Cooke A; Hay FC Eur J Immunol; 1990 Oct; 20(10):2229-33. PubMed ID: 2242757 [TBL] [Abstract][Full Text] [Related]
10. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy. Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333 [TBL] [Abstract][Full Text] [Related]
11. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Jefferis R; Lund J; Pound JD Immunol Rev; 1998 Jun; 163():59-76. PubMed ID: 9700502 [TBL] [Abstract][Full Text] [Related]
13. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Arnold JN; Dwek RA; Rudd PM; Sim RB Immunol Lett; 2006 Aug; 106(2):103-10. PubMed ID: 16814399 [TBL] [Abstract][Full Text] [Related]
14. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Gornik I; Maravić G; Dumić J; Flögel M; Lauc G Clin Biochem; 1999 Nov; 32(8):605-8. PubMed ID: 10638942 [TBL] [Abstract][Full Text] [Related]
15. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. Wright A; Morrison SL J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299 [TBL] [Abstract][Full Text] [Related]
16. Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors. Adler Y; Lamour A; Jamin C; Menez JF; Le Corre R; Shoenfeld Y; Youinou P Clin Exp Rheumatol; 1995; 13(3):315-9. PubMed ID: 7554557 [TBL] [Abstract][Full Text] [Related]
17. Carbamylation reduces the capacity of IgG for hexamerization and complement activation. Lubbers R; Oostindie SC; Dijkstra DJ; Parren PWHI; Verheul MK; Abendstein L; Sharp TH; de Ru A; Janssen GMC; van Veelen PA; van den Bremer ETJ; Bleijlevens B; de Kreuk BJ; Beurskens FJ; Trouw LA Clin Exp Immunol; 2020 Apr; 200(1):1-11. PubMed ID: 31853959 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. Alavi A; Arden N; Spector TD; Axford JS J Rheumatol; 2000 Jun; 27(6):1379-85. PubMed ID: 10852257 [TBL] [Abstract][Full Text] [Related]
19. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Nimmerjahn F; Anthony RM; Ravetch JV Proc Natl Acad Sci U S A; 2007 May; 104(20):8433-7. PubMed ID: 17485663 [TBL] [Abstract][Full Text] [Related]
20. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]